Clinical trial retention starts before randomization
A 2024 analysis of nearly 800 trials found that the harder a consent form was to read, the more patients dropped out. The decision to stay is often made long before randomization. Here is what that means for how studies recruit.
That Is a Wrap: 1nHealth at DIA 2026
Our team spent the week in Philadelphia at DIA 2026. Here is what we are taking home.
June is Men’s Health Week
The pattern is well documented. Men are more likely to skip routine screenings, delay care, and stay silent about symptoms until they become serious…
The gap between Alzheimer’s research and the people who need it most
For Dan, CEO and founder of 1nHealth, Alzheimer’s disease is not a therapeutic area on a strategy deck. He lost his grandmother to it. That loss is part of why he built this company, and part of why closing the distance between Alzheimer’s research and the communities it was designed to serve sits at the center of what 1nHealth does.
The pre-launch projection problem: why sponsors pivot too late and what it costs them
When real-world enrollment data contradicts the plan, most sponsors wait. Our founder explains why that wait is never free.